Group One Trading
XENE icon

Group One Trading’s Xenon Pharmaceuticals XENE Stock Holding History

Group One Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.1M Buy
53,300
+40,800
+326% +$1.88M 0.01% 1683
2025
Q4 		$560K Buy
12,500
+4,100
+49% +$172K ﹤0.01% 3392
2025
Q3 		$337K Sell
8,400
-6,800
-45% -$240K ﹤0.01% 4114
2025
Q2 		$476K Buy
+15,200
New +$496K ﹤0.01% 3473
2025
Q1 		– Sell
-500
Closed -$19.6K – 8474
2024
Q4 		$19.6K Sell
500
-15,500
-97% -$641K ﹤0.01% 5698
2024
Q3 		$630K Sell
16,000
-23,400
-59% -$943K ﹤0.01% 2689
2024
Q2 		$1.54M Sell
39,400
-195,000
-83% -$7.79M 0.01% 1660
2024
Q1 		$10.1M Buy
234,400
+145,600
+164% +$6.7M 0.04% 438
2023
Q4 		$4.09M Buy
88,800
+69,600
+363% +$2.46M 0.01% 1284
2023
Q3 		$656K Buy
19,200
+900
+5% +$33.7K ﹤0.01% 2649
2023
Q2 		$705K Sell
18,300
-22,400
-55% -$890K ﹤0.01% 2677
2023
Q1 		$1.46M Buy
40,700
+29,400
+260% +$1.09M 0.01% 1805
2022
Q4 		$446K Buy
11,300
+11,200
+11,200% +$408K ﹤0.01% 3150
2022
Q3 		$4K Sell
100
-100
-50% -$3.6K ﹤0.01% 6964
2022
Q2 		$6K Sell
200
-1,900
-90% -$57.5K ﹤0.01% 7042
2022
Q1 		$64K Sell
2,100
-12,900
-86% -$386K ﹤0.01% 5914
2021
Q4 		$469K Sell
15,000
-84,900
-85% -$2.54M ﹤0.01% 4201
2021
Q3 		$1.53M Buy
99,900
+95,700
+2,279% +$1.66M ﹤0.01% 2943
2021
Q2 		$78K Hold
4,200
– – ﹤0.01% 6197
2021
Q1 		$75K Buy
+4,200
New +$71.2K ﹤0.01% 5914
2020
Q1 		– Sell
-2,400
Closed -$31K – 5813
2019
Q4 		$31K Buy
2,400
+2,300
+2,300% +$24.2K ﹤0.01% 4212
2019
Q3 		$1K Hold
100
– – ﹤0.01% 5021
2019
Q2 		$1K Buy
+100
New +$957 ﹤0.01% 4845
2019
Q1 		– Sell
-100
Closed -$6K – 5438
2018
Q4 		$6K Buy
+100
New +$889 ﹤0.01% 4447

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Group One Trading's XENE Position: Q4 2025 in Review

Group One Trading sold out of Xenon Pharmaceuticals (XENE) in Q4 2025, closing a stake of 3,556 shares — an estimated $149K sold.

Group One Trading first reported a position in XENE in Q2 2021 and held it in 10 quarters. The position peaked at $418K in Q3 2022. 246 funds tracked by Wall St. Rank hold XENE as of Q4 2025.

  • Group One Trading reported no remaining Xenon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 3,556 Xenon Pharmaceuticals shares in Q4 2025, an estimated $149K.
  • Group One Trading first reported a position in Xenon Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • Group One Trading's Xenon Pharmaceuticals position peaked at $418K in Q3 2022.
  • 246 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.